MTG201 + nivolumab

· Momotaro-Gene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MTG201 + nivolumab, covering 2022-06-16 to 2022-06-16. Get the full timeline:

Most recent: Clinical Trial Update: MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma [Phase 2]